Status:
UNKNOWN
Appropriateness of Aspirin Use in Medical Outpatients
Lead Sponsor:
Muğla Sıtkı Koçman University
Conditions:
Primary Prevention of Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to describe the demographic characteristics and current status of the aspirin use for primary and secondary prevention of cardiovascular diseases in a large, multicenter nationwide stu...
Detailed Description
Although the benefit of aspirin use for secondary prevention is well established, its role in the primary prevention of cardiovascular diseases remains controversial. Differences in primary prevention...
Eligibility Criteria
Inclusion
- Patients using aspirin 18 years and older
Exclusion
- Patients under 18 years of age
- Patients who do not want to participate in our study
- Patients who do not use aspirin
Key Trial Info
Start Date :
June 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2019
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03387384
Start Date
June 30 2018
End Date
July 30 2019
Last Update
December 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mugla Sitki Kocman University Training and Research Hospital
Muğla, Turkey (Türkiye)